MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$12,967K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Net gain on lease termination
    • Accounts payable
    • Prepaid research and development
    • Others
Negative Cash Flow Breakdown
    • Net Income Loss
    • Right of use assets and operatin...
    • Accrued expenses and other curre...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Sharebased compensation
556 609 611 1,781
Amortization of premium and discount on marketable securities, net
NaN 0 0 129
Impairment of long-lived assets
NaN 3,508 2,637 NaN
Other non-cash items
NaN 0 0 14
Net gain on lease termination
633 NaN NaN NaN
Prepaid expenses and other current assets, and other assets
53 -1,034 235 571
Depreciation Depletion And Amortization
129 177 181 370
Prepaid research and development
-107 -490 33 66
Non-refundable sublicense and transition services payments received
NaN 0 2,500 1,515
Right of use assets and operating lease liabilities
4,973 127 122 215
Accounts payable
197 161 66 1,653
Accrued expenses and other current liabilities
-758 652 -72 -2,634
Net Income Loss
-7,600 -12,983 -32,539 NaN
Net gain on lease termination
600 NaN NaN NaN
Net cash provided by (used in) operating activities
-12,987 -6,479 -4,853 -20,177
Sale of property and equipment and other assets
NaN NaN 0 1,170
Sales or maturities of marketable securities
NaN 0 0 39,046
Sales of property and equipment and other assets
20 1,170 NaN NaN
Net cash provided by (used in) investing activities
20 0 0 40,216
Proceeds from the issuance of common stock under employee stock purchase plan
NaN 9 0 14
Net cash provided by (used in) financing activities
NaN 9 0 14
Net increase (decrease) in cash and cash equivalents
-12,967 NaN NaN NaN
Net increase (decrease) in cash and cash equivalents
-12,967 -6,470 -4,853 20,053
Cash and cash equivalents at beginning of period
46,303 52,773 37,573 NaN
Cash and cash equivalents at end of period
33,336 46,303 52,773 NaN
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Sales of property andequipment and other assets$20K Net increase(decrease) in cash and cash...-$12,967K Net cash provided by(used in) investing...$20K Net gain on leasetermination$633K Prepaid expenses andother current assets,...$53K Net increase(decrease) in cash and cash...-$12,967K Canceled cashflow$20K Accounts payable$197K Depreciation Depletion AndAmortization$129K Prepaid research anddevelopment-$107K Canceled cashflow$556K Net cash provided by(used in) operating...-$12,987K Canceled cashflow$433K Sharebased compensation$556K Net Income Loss-$7,600K Right of use assets andoperating lease...$4,973K Accrued expenses andother current...-$758K Net gain on leasetermination$600K

Passage BIO, Inc. (PASG)

Passage BIO, Inc. (PASG)